Legislation that would allow HHS to stop unjustifiable drug price hikes has been introduced by Sen. Richard Blumenthal, D-Conn., and three other Senate Democrats. The CURE High Drug Prices Act will permit HHS to force pharmaceutical firms to pay back unjustifiable increases in drug prices to payers and other consumers if the agency deems a price hike is excessive or to bring back the drug's old price for a certain period under qualified or federal health plans.
Senate bill seeks to stop excessive drug price hikes
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.